Scarica l'app Stockscreener
229.34
0.46%
1.2588
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$228.08
Aprire:
$228.15
Volume 24 ore:
79,027
Relative Volume:
0.04
Capitalizzazione di mercato:
$66.11B
Reddito:
$20.64B
Utile/perdita netta:
$1.73B
Rapporto P/E:
38.10
EPS:
6.02
Flusso di cassa netto:
$2.94B
1 W Prestazione:
-1.15%
1M Prestazione:
+0.67%
6M Prestazione:
-3.43%
1 anno Prestazione:
-5.28%
Intervallo 1D:
$227.22
$229.30
Intervallo di 1 settimana:
$226.48
$233.07
Portata 52W:
$218.75
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Confronta BDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
229.30 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ISRG
Intuitive Surgical Inc
|
514.07 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
ALC
Alcon Inc
|
91.44 | 45.01B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.97 | 32.73B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.01 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Was Jim Cramer Right About Becton, Dickinson and Company (BDX)? - Insider Monkey
Insider Sell: Richard Byrd Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus.com
FDA tags Becton, Dickinson and Company infusion software recall as Class I - Yahoo Finance
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Becton Dickinson and : BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance - Marketscreener.com
Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial -March 20, 2025 at 07:56 am EDT - Marketscreener.com
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery - Quantisnow
Becton Dickinson EVP Richard Byrd sells $105,570 in stock By Investing.com - Investing.com Australia
Becton Dickinson EVP Richard Byrd sells $105,570 in stock - Investing.com
SEC Form 144 filed by Becton Dickinson and Company - Quantisnow
Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock - Yahoo Finance
How Do Investors Really Feel About Becton Dickinson? - Benzinga
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Becton, Dickinson, And Company Stock: Is BDX Underperforming The Healthcare Sector? - Barchart
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector? - Inkl
Becton, Dickinson and Company (NYSE:BDX) Stock Price Down 0.3% Following Insider Selling - Defense World
Becton Dickinson EVP Richard Byrd sells $436,325 in stock By Investing.com - Investing.com South Africa
BD to acquire Bard - Covington News
Becton Dickinson EVP Richard Byrd sells $436,325 in stock - Investing.com India
Becton Dickinson Says Ex-Exec Broke Non-Compete, Stole Secrets - Bloomberg Law
Becton Dickinson at Barclays Conference: Strategic Medtech Shift By Investing.com - Investing.com Canada
Becton Dickinson at Barclays Conference: Strategic Medtech Shift - Investing.com
Fisher Asset Management LLC Has $202,000 Stake in Becton, Dickinson and Company (NYSE:BDX) - Defense World
Dividend Aristocrats In Focus: Becton, Dickinson & Co. - Sure Dividend
Becton, Dickinson and Company (NYSE:BDX) Upgraded at StockNews.com - Defense World
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus.com
December 2026 Options Now Available For Becton, Dickinson (BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Stock Rating Lowered by StockNews.com - Defense World
BD East Africa, Safaricom to compensate ex-staff over privacy breach - Capital FM Kenya
BD Packaging Innovations Get Under Patients’ Skin - Packaging Digest
Head to Head Contrast: Universal Media Group (OTCMKTS:UMGP) vs. Becton, Dickinson and Company (NYSE:BDX) - Defense World
Argus Adjusts Becton Dickinson and Co.'s Price Target to $270 From $290 -February 21, 2025 at 10:39 am EST - Marketscreener.com
BD business separation could allow competitors to rise in IVD test markets - Medical Device Network
BD Recalls ChloraPrep Clear 1 ML Applicators - Nasdaq
Becton, Dickinson and Company's SWOT analysis: med tech giant's stock poised for growth - Investing.com India
Do Wall Street Analysts Like Becton, Dickinson and Company Stock? - Inkl
Becton Dickinson and : BD Announces Voluntary Worldwide Recall for One Lot of ChloraPrep™ Clear 1 mL Applicators Due to Fungal Contamination - Marketscreener.com
Chevy Chase Trust Holdings LLC Cuts Position in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
MADDEN SECURITIES Corp Invests $407,000 in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Louisbourg Investments Inc. Increases Stake in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Vontobel Holding Ltd. - MarketBeat
Kanawha Capital Management LLC Has $18.82 Million Stock Holdings in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Jmac Enterprises LLC Makes New Investment in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson director Scott Bertram sells $159,593 in stock - MSN
Barclays Adjusts Price Target on Becton, Dickinson and Company to $279 From $278 - Marketscreener.com
Becton Dickinson gains amid reports it's evaluating separating life sciences unit - MSN
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.95%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):